Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Endometrial Cancer: early-phase trial registry
108 of 188 indexed Endometrial Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #59 of 28,707 conditions by registered trial count.
188 US clinical trials · 108 currently recruiting · #59 of 28,707 conditions by registered trial count
Endometrial Cancer: 188 US clinical trials tracked, 108 recruiting.
Endometrial Cancer is the subject of 188 registered US clinical trials on ClinicalTrials.gov, 108 of them currently open to new participants. 15 are in Phase 3-4 (later-stage) and 118 in Phase 1-2 (earlier-stage). The most active sponsor is Memorial Sloan Kettering Cancer Center, running 17 of these trials.
Enrollment posture brief
Registry condition endometrial-cancer
OPEN 108 | RECR 57% | LATE 15 | EARLY 118 | RANK #59 | SPON 17
Volume-matched condition peers
Nearest open-share peer: Mesothelioma (57% recruiting · 47 trials)
Endometrial Cancer lists 108 open slots (57% of 188 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Endometrial Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Endometrial Cancer is recruiting above its size-band peers.
108 of 188 indexed trials (57.4%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Endometrial Cancer trials is spread across many organizations.
Memorial Sloan Kettering Cancer Center accounts for 17 of 188 trials (9%). 116 distinct sponsors appear on at least one study for this condition label.
-
Typical Endometrial Cancer enrolment sits around 108 participants.
Median target enrolment is 108 among the 182 trials that report a genuine target (sentinel values excluded). 85 of those (46.7%) plan for fewer than 100 participants.
-
Endometrial Cancer research is mostly interventional.
167 interventional and 21 observational studies make up this index (88.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
188 total, page 4 of 4
Lymph Node Mapping in Patients With Endometrial Cancer
Ohio State University Comprehensive Cancer Center
NCT01818739
A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
Novadaq Technologies ULC, now a part of Stryker
NCT02209532
Scale Down for Endometrial Cancer
Washington University School of Medicine
NCT03169023
Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma
Memorial Sloan Kettering Cancer Center
NCT00595725
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Incyte Corporation
NCT03314935
FitEx for Endometrial Cancer Survivors: Initial Efficacy
Carilion Clinic
NCT05737745
Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
Memorial Sloan Kettering Cancer Center
NCT01738152
Lymphedema in Endometrial Cancer
Duke University
NCT01914276
Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.
Mundipharma Research Limited
NCT03345485
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment
Eli Lilly and Company
NCT00190697
Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
GlaxoSmithKline
NCT00267488
Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients
Washington University School of Medicine
NCT00334321
SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
Byondis B.V.
NCT04205630
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
NCT00474994
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
National Cancer Institute (NCI)
NCT00033358
Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
University of Oklahoma
NCT03476798
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
Arcus Biosciences
NCT03629756
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Cancer Institute (NCI)
NCT00924027
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
David O'Malley
NCT00513786
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Santa Maria Biotherapeutics
NCT02262455
Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
UNC Lineberger Comprehensive Cancer Center
NCT00099008
the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer
Sanford Health
NCT03908996
A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
UNC Lineberger Comprehensive Cancer Center
NCT02767362
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
Dana-Farber Cancer Institute
NCT00268918
A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
NYU Langone Health
NCT02744898
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma
Northwell Health
NCT04080284
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
NCT00388154
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers
Dana-Farber Cancer Institute
NCT00545792
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
M.D. Anderson Cancer Center
NCT01205672
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
Masonic Cancer Center, University of Minnesota
NCT00610740
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
SCRI Development Innovations
NCT00315861
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
University of Wisconsin, Madison
NCT02096783
Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
Gynecologic Oncology Group
NCT00005031
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
NYU Langone Health
NCT00003334
Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer
Radiation Therapy Oncology Group
NCT00006027
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
Beth Israel Deaconess Medical Center
NCT00004082
Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer
Memorial Sloan Kettering Cancer Center
NCT00006377
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
Gynecologic Oncology Group
NCT00002493
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 74 |
| Phase 2 | 44 |
| Phase 3 | 14 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Endometrial Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Endometrial Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Endometrial Cancer page
188 registered trials, 108 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 108 Endometrial Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Memorial Sloan Kettering Cancer Center sponsors the most Endometrial Cancer trials on record, review their full trial history before evaluating a specific study. See Memorial Sloan Kettering Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Endometrial Cancer condition card totals 188 registered trials; most-linked intervention Paclitaxel; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.